Literature DB >> 10560677

A haemorrhagic fever from the Côte d'Ivoire.

D Teichmann1, M P Grobusch, H Wesselmann, B Temmesfeld-Wollbrück, T Breuer, M Dietel, P Emmerich, H Schmitz, N Suttorp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10560677     DOI： 10.1016/s0140-6736(99)09233-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  False-negative results of PCR assay with plasma of patients with severe viral hemorrhagic fever.

Authors:  Christian Drosten; Marcus Panning; Stephan Guenther; Herbert Schmitz
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Yellow Fever Immunizations: Indications and Risks.

Authors:  Mary E. Wilson; Lin H. Chen; Elizabeth D. Barnett
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

3.  Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories.

Authors:  Cristina Domingo; Pranav Patel; Jasmin Yillah; Manfred Weidmann; Jairo A Méndez; Emmanuel Rivalyn Nakouné; Matthias Niedrig
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

4.  Incubation periods of Yellow fever virus.

Authors:  Michael A Johansson; Neysarí Arana-Vizcarrondo; Brad J Biggerstaff; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

5.  Developing national epidemiologic capacity to meet the challenges of emerging infections in Germany.

Authors:  L R Petersen; A Ammon; O Hamouda; T Breuer; S Kiessling; B Bellach; U Niemer; F J Bindert; S Ostroff; R Kurth
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

6.  Advanced age a risk factor for illness temporally associated with yellow fever vaccination.

Authors:  M Martin; L H Weld; T F Tsai; G T Mootrey; R T Chen; M Niu; M S Cetron
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

7.  Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

Authors:  Christian Drosten; Stephan Göttig; Stefan Schilling; Marcel Asper; Marcus Panning; Herbert Schmitz; Stephan Günther
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

8.  Vaccination in HIV-infected Patients.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.663

9.  Viruses Causing Hemorrhagic Fever. Safety Laboratory Procedures.

Authors:  Fernando Cobo
Journal:  Open Virol J       Date:  2016-01-15

10.  Emergency department evaluation of the febrile traveler.

Authors:  David C Pigott
Journal:  J Infect       Date:  2006-05-23       Impact factor: 6.072
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.